Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Cresco Labs Inc. is a U.S.-focused, vertically integrated cannabis company operating across the cannabis cultivation, manufacturing, branded consumer packaged goods, and retail dispensary industries. The company’s core business is the production and sale of regulated cannabis products for medical and adult-use markets in the United States, with revenue primarily generated through wholesale distribution of branded products and company-operated retail sales.
Founded in 2013, Cresco Labs evolved from a single-state operator into a multi-state operator by pursuing a strategy centered on brand development, scaled cultivation, and selective retail presence. The company is recognized for its emphasis on high-volume wholesale distribution, a portfolio of nationally recognizable cannabis brands, and disciplined market selection focused on limited-license and high-growth U.S. states.
Business Operations
Cresco Labs operates through two primary business segments: Cultivation & Manufacturing and Retail. The Cultivation & Manufacturing segment produces branded cannabis products, including flower, vapes, edibles, and concentrates, which are sold through third-party dispensaries and Cresco-owned stores. The Retail segment operates dispensaries under the Sunnyside brand, generating revenue directly from consumers in both medical and adult-use markets.
Operations are entirely U.S.-based due to federal cannabis regulations. Cresco Labs controls licensed cultivation facilities, processing labs, distribution infrastructure, and retail assets. The company has historically expanded through acquisitions and license wins, including the integration of Origin House and Bluma Wellness, and maintains wholly owned subsidiaries aligned to state-level regulatory requirements. No international plant-touching operations are conducted.
Strategic Position & Investments
Cresco Labs’ strategy emphasizes brand leadership, operational efficiency, and strong wholesale market share in limited-license states. Growth initiatives have focused on increasing penetration of core brands such as Cresco, High Supply, Mindy’s Edibles, Good News, FloraCal Farms, and Remedi, while optimizing underperforming assets and exiting non-core markets to preserve capital.
The company has made significant investments in cultivation scale, retail optimization, and brand development rather than broad geographic expansion. A previously announced merger with Columbia Care was mutually terminated in 2023, reflecting a strategic pivot toward balance sheet preservation and organic performance improvement. Emerging focus areas include premium branded products, data-driven retail, and operational automation, though long-term impacts remain subject to market and regulatory conditions.
Geographic Footprint
Cresco Labs is headquartered in Chicago, Illinois, and operates across key U.S. cannabis markets, primarily in the Midwest, Northeast, and select Eastern U.S. states. Core operating states have included Illinois, Pennsylvania, Ohio, Michigan, Massachusetts, New York, and Florida, with market participation evolving over time based on asset optimization decisions.
The company does not operate outside the United States and has no direct exposure to international cannabis markets. Its geographic strategy prioritizes states with limited licensing structures, strong population density, and favorable regulatory frameworks, enabling both wholesale scale and brand visibility.
Leadership & Governance
Cresco Labs is led by a management team with experience in consumer packaged goods, operations, and regulated industries. The leadership philosophy emphasizes disciplined growth, compliance, brand consistency, and long-term value creation within the constraints of U.S. cannabis regulation.
Key executives include:
- Charlie Bachtell – Chief Executive Officer
- Gary Santos – Chief Financial Officer
- Jon Spach – Chief Operating Officer
The company was co-founded by Charlie Bachtell, who has played a central role in shaping Cresco Labs’ vertically integrated model and wholesale-focused strategy. Governance is overseen by a board of directors with backgrounds in finance, operations, and regulated consumer markets, though specific committee structures and mandates are disclosed in company regulatory filings.